Montelukast in guidelines and beyond

被引：20
作者：
Bousquet, Jean [1 ]
Demoly, Pascal [1 ,2 ]
Humbert, Marc [3 ]
机构：
[1] Hop Arnaud Villeneuve, Serv Malad Resp, F-34275 Montpellier 5, France
[2] INSERM, U657, F-75654 Paris 13, France
[3] Univ Paris 11, Hop Antoine Beclere, Clamart, France
来源：
ADVANCES IN THERAPY | 2009年 / 26卷 / 06期
关键词：
allergic rhinitis; asthma; guidelines; inhaled corticosteroids; montelukast; rhinitis; LEUKOTRIENE-RECEPTOR ANTAGONIST; SEASONAL ALLERGIC RHINITIS; TERM CLINICAL-TRIAL; INHALED CORTICOSTEROIDS; ASTHMA CONTROL; DOUBLE-BLIND; PRESCHOOL-CHILDREN; ORAL MONTELUKAST; MILD ASTHMA; PLACEBO;
D O I：
10.1007/s12325-009-0038-1
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
In all asthma guidelines, preventive anti-inflammatory treatment is essential in all patients with persistent asthma. Inhaled corticosteroids are the mainstay of treatment in the control of asthma, but other treatments may be used as a monotherapy in patients with mild asthma or as an add-on treatment in those with moderate-to-severe asthma. Leukotriene modifiers are the only validated preventive treatment for all age groups. This review discusses the place of montelukast, a leukotriene receptor antagonist, using guidelines and consensus reports on asthma and rhinitis: the US National Asthma Education and Prevention Program (NAEPP); the British Guideline on the Management of Asthma; the Global Initiative on Asthma (GINA); and Allergic Rhinitis and its Impact on Asthma (ARIA). This review includes new studies that have not yet been considered in guidelines.
引用
收藏
页码：575 / 587
页数：13
相关论文
共 73 条
  • [1] The socio-economic burden of asthma is substantial in Europe
    Accordini, S.
    Corsico, A.
    Cerveri, I.
    Gislason, D.
    Gulsvik, A.
    Janson, C.
    Jarvis, D.
    Marcon, A.
    Pin, I.
    Vermeire, P.
    Almar, E.
    Bugiani, M.
    Cazzoletti, L.
    Duran-Tauleria, E.
    Jogi, R.
    Marinoni, A.
    Martinez-Moratalla, J.
    Leynaert, B.
    de Marco, R.
    [J]. ALLERGY, 2008, 63 (01) : 116 - 124
  • [2] Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report
    Bacharier, L. B.
    Boner, A.
    Carlsen, K. -H.
    Eigenmann, P. A.
    Frischer, T.
    Goetz, M.
    Helms, P. J.
    Hunt, J.
    Liu, A.
    Papadopoulos, N.
    Platts-Mills, T.
    Pohunek, P.
    Simons, F. E. R.
    Valovirta, E.
    Wahn, U.
    Wildhaber, J.
    [J]. ALLERGY, 2008, 63 (01) : 5 - 34
  • [3] Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing
    Bacharier, Leonard B.
    Phillips, Brenda R.
    Zeiger, Robert S.
    Szefler, Stanley J.
    Martinez, Fernando D.
    Lemanske, Robert F., Jr.
    Sorkness, Christine A.
    Bloomberg, Gordon R.
    Morgan, Wayne J.
    Paul, Ian M.
    Guilbert, Theresa
    Krawiec, Marzena
    Covar, Ronina
    Larsen, Gary
    Mellon, Michael
    Moss, Mark H.
    Chinchilli, Vernon M.
    Taussig, Lynn M.
    Strunk, Robert C.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (06) : 1127 - 1135
  • [4] Comparative effects of desloratadine versus montelukast on asthma symptoms and use of β2-agonists in patients with seasonal allergic rhinitis and asthma
    Baena-Cagnani, CE
    Berger, WE
    DuBuske, LM
    Gurné, SE
    Stryszak, P
    Lorber, R
    Danzig, M
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2003, 130 (04) : 307 - 313
  • [5] The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life:: a GA2LEN review
    Baiardini, I.
    Braido, F.
    Brandi, S.
    Tarantini, F.
    Bonini, S.
    Bousquet, P. J.
    Zuberbier, T.
    Demoly, P.
    Canonica, G. W.
    [J]. ALLERGY, 2008, 63 (08) : 1015 - 1030
  • [6] The national montelukast survey
    Barnes, N
    Thomas, M
    Price, D
    Tate, H
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (01) : 47 - 54
  • [7] Global strategy for asthma management and prevention: GINA executive summary
    Bateman, E. D.
    Hurd, S. S.
    Barnes, P. J.
    Bousquet, J.
    Drazen, J. M.
    FitzGerald, M.
    Gibson, P.
    Ohta, K.
    O'Byrne, P.
    Pedersen, S. E.
    Pizzichini, E.
    Sullivan, S. D.
    Wenzel, S. E.
    Zar, H. J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) : 143 - 178
  • [8] Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
    Baumgartner, RA
    Martinez, G
    Edelman, JM
    Gomez, GGR
    Bernstein, M
    Bird, S
    Angner, R
    Polis, A
    Dass, SB
    Lu, S
    Reiss, TF
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (01) : 123 - 128
  • [9] Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study
    Becker, Allan B.
    Kuznetsova, Olga
    Vermeulen, J.
    Soto-Quiros, Manuel E.
    Young, Betty
    Reiss, Theodore F.
    Dass, S. Balachandra
    Knorr, Barbara A.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 96 (06) : 800 - 807
  • [10] Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma
    Bisgaard, H
    Zielen, S
    Garcia-Garcia, ML
    Johnston, SL
    Gilles, L
    Menten, J
    Tozzi, CA
    Polos, P
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (04) : 315 - 322
12345678